Vir Biotechnology, Inc. (NASDAQ:VIR) Q1 2026 Earnings Call Transcript
Operator: Hello, and welcome to Vir Biotechnology, Inc. First Quarter 2026 Financial Results and Corporate Update Conference Call. As a reminder, this call is being recorded.
Vir Biotechnology Inc. (VIR)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | ADAR1 Capital Management Daniel Schneeberger | 2,744,714 | $24,592,637 | 1.45% | |
| 2. | Citadel Investment Group Ken Griffin | 2,098,476 | $18,802,345 | +329% | 0% |
| 3. | Soleus Capital Guy Levy | 2,002,000 | $17,937,920 | 0.73% | |
| 4. | Point72 Asset Management Steve Cohen | 1,952,234 | $17,492,017 | +898% | 0.02% |
| 5. | Boxer Capital Aaron Davis And Christopher Fuglesang | 1,866,000 | $16,719,360 | +199% | 2.2% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $22.73 | 2,500 | $56,815.50 | 10,000 | 2023-03-01 | Filing | |
| $24.96 | 2,500 | $62,395.50 | 7,500 | 2023-01-05 | Filing | |
| $25.25 | 2,500 | $63,136.25 | 5,000 | 2023-01-04 | Filing | |
| $25.60 | 2,500 | $63,992.50 | 2,500 | 2023-01-03 | Filing | |
| $43.39 | 12 | $499.85 | 12 | 2021-11-29 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $9.45 | 3,200 | $30,240.00 | 21,216 | 2026-06-01 | Filing | |
| $9.45 | 379 | $3,581.55 | 61,902 | 2026-06-01 | Filing | |
| $10.05 | 22,000 | $221,025.20 | 1,078,391 | 2026-05-01 | Filing | |
| $9.16 | 72,559 | $664,350.20 | 948,145 | 2026-04-06 | Filing | |
| $9.07 | 22,000 | $199,617.00 | 1,100,391 | 2026-04-01 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 17,998,329 | $161,265,028 | 0% | |
| 2. | 12,916,663 | $115,733,300 | 17.09% | |
| 3. | 10,948,093 | $98,094,913 | 1.27% | |
| 4. | 9,215,577 | $82,571,570 | 0% | |
| 5. | 8,550,954 | $76,616,548 | 12.79% |
News See All
Is Vir Biotechnology, Inc. (VIR) A Good Stock To Buy Now?
Is VIR a good stock to buy? We came across a bullish thesis on Vir Biotechnology, Inc. on BioEquity Watch’s Substack. In this article, we will summarize the bulls’ thesis on VIR.
10 Best Small-Cap Biotech Stocks to Buy According to Hedge Funds
On February 16, Franklin Equity said the biotechnology industry has entered 2026 on a firmer footing following an extended period of market uncertainty in the prior year, noting that market attention ...
Is Vir Biotechnology (VIR) One of the Best Low Priced Biotech Stocks to Invest In?
Vir Biotechnology, Inc. (NASDAQ:VIR) is one of the best low priced biotech stocks to invest in. On April 13, Vir Biotechnology, Inc.
8 Must-Buy Small Cap Stocks to Buy
After many years of large capitalization companies dominating the US equities market, time is ripe for rotation.
8 Best Low Priced Biotech Stocks to Invest In
On April 16, Fundstrat’s Tom Lee appeared on CNBC's 'Closing Bell' to talk about what to expect from equity markets going forward.
Vir Biotechnology (VIR) Leading with Its BiTEs Therapy
Jacob Funds, a mutual fund company, released its first-quarter 2026 investor letter. A copy of the letter can be downloaded here.
Vir Biotechnology, Inc. (NASDAQ:VIR) Q4 2025 Earnings Call Transcript
Operator: Good afternoon, and welcome to Vir Biotechnology's conference call to discuss the company's VIR-5500 Strategic Collaboration with Astellas and Positive Phase I Data, and 2025 financial results...
Vir Biotechnology, Inc. (NASDAQ:VIR) Q3 2025 Earnings Call Transcript
Operator: Hello, and welcome to Vir Biotechnology's Third Quarter 2025 Financial Results and Corporate Update Call. As a reminder, this conference call is being recorded.
Vir Biotechnology, Inc. (NASDAQ:VIR) Q2 2025 Earnings Call Transcript
Operator: Hello. Welcome to Vir Biotechnology's Second Quarter 2025 Financial Results and Corporate Update Call. As a reminder, this conference call is being recorded.
Hedge Fund Resource Center